Literature DB >> 30590101

Cancer-associated acinar-to-ductal metaplasia within the invasive front of pancreatic cancer contributes to local invasion.

Shin Kibe1, Kenoki Ohuchida2, Yohei Ando1, Shin Takesue1, Hiromichi Nakayama1, Toshiya Abe1, Sho Endo1, Kazuhiro Koikawa1, Takashi Okumura1, Chika Iwamoto3, Koji Shindo1, Taiki Moriyama4, Kohei Nakata1, Yoshihiro Miyasaka1, Masaya Shimamoto5, Takao Ohtsuka1, Kazuhiro Mizumoto5, Yoshinao Oda6, Masafumi Nakamura7.   

Abstract

The pancreas is an organ prone to inflammation, fibrosis, and atrophy because of an abundance of acinar cells that produce digestive enzymes. A characteristic of pancreatic cancer is the presence of desmoplasia, inflammatory cell infiltration, and cancer-associated acinar atrophy (CAA) within the invasive front. CAA is characterized by a high frequency of small ducts and resembles acinar-to-ductal metaplasia (ADM). However, the clinical significance of changes in acinar morphology, such as ADM with acinar atrophy, within the tumor microenvironment remains unclear. Here, we find that ADM within the invasive front of tumors is associated with cell invasion and desmoplasia in an orthotopic mouse model of pancreatic cancer. An analysis of resected human tumors revealed that regions of cancer-associated ADM were positive for TGFα, and that this TGFα expression was associated with primary tumor size and shorter survival times. Gene expression analysis identified distinct phenotypic profiles for cancer-associated ADM, sporadic ADM and chronic pancreatitis ADM. These findings suggest that the mechanisms driving ADM differ according to the specific tissue microenvironment and that cancer-associated ADM and acinar atrophy contribute to tumor cell invasion of the local pancreatic parenchyma.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ADM; Acinar atrophy; Local invasion; Pancreatic cancer; Tumor microenvironment

Mesh:

Substances:

Year:  2018        PMID: 30590101     DOI: 10.1016/j.canlet.2018.12.005

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  6 in total

Review 1.  Molecular signaling in pancreatic ductal metaplasia: emerging biomarkers for detection and intervention of early pancreatic cancer.

Authors:  Xiaojia Li; Jie He; Keping Xie
Journal:  Cell Oncol (Dordr)       Date:  2022-03-15       Impact factor: 6.730

2.  Imidazo[2,1-b]thiazole-Coupled Natural Noscapine Derivatives as Anticancer Agents.

Authors:  Praveen Kumar Reddy Nagireddy; Vamsi Krishna Kommalapati; Vagolu Siva Krishna; Dharmarajan Sriram; Anjana Devi Tangutur; Srinivas Kantevari
Journal:  ACS Omega       Date:  2019-11-05

3.  The EGFR-HSF1 axis accelerates the tumorigenesis of pancreatic cancer.

Authors:  Weikun Qian; Ke Chen; Tao Qin; Ying Xiao; Jie Li; Yangyang Yue; Cancan Zhou; Jiguang Ma; Wanxing Duan; Jianjun Lei; Liang Han; Li Li; Xin Shen; Zheng Wu; Qingyong Ma; Zheng Wang
Journal:  J Exp Clin Cancer Res       Date:  2021-01-09

4.  LGR5 expression and clinicopathological features of the invasive front in the fat infiltration area of pancreatic cancer.

Authors:  Masato Kamakura; Takeshi Uehara; Mai Iwaya; Shiho Asaka; Shota Kobayashi; Tomoyuki Nakajima; Yasuhiro Kinugawa; Tadanobu Nagaya; Takahiro Yoshizawa; Akira Shimizu; Hiroyoshi Ota; Takeji Umemura
Journal:  Diagn Pathol       Date:  2022-02-05       Impact factor: 2.644

5.  NGF from pancreatic stellate cells induces pancreatic cancer proliferation and invasion by PI3K/AKT/GSK signal pathway.

Authors:  Jie Jiang; Jun Bai; Tao Qin; Zheng Wang; Liang Han
Journal:  J Cell Mol Med       Date:  2020-04-15       Impact factor: 5.310

6.  High-resolution Hi-C maps highlight multiscale 3D epigenome reprogramming during pancreatic cancer metastasis.

Authors:  Bo Ren; Jinshou Yang; Chengcheng Wang; Gang Yang; Huanyu Wang; Yuan Chen; Ruiyuan Xu; Xuning Fan; Lei You; Taiping Zhang; Yupei Zhao
Journal:  J Hematol Oncol       Date:  2021-08-04       Impact factor: 17.388

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.